stockrowIllumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.
- Revenue
- +4.15%
- EPS
- +49.0%
- Free cash flow
- +49.8%
- Total debt
- +80.0%
Quarter to September 2026, against a year earlier
Follow ILMN
Alert me
Illumina, Inc. (ILMN) Gross margin
Illumina, Inc.'s gross margin over the twelve months to 30 September 2026 was 67.9%, up 1.8 percentage points from fiscal 2025 (66.1%). Over the past ten years it has ranged from 60.9% (fiscal 2023) to 69.8% (fiscal 2015); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 48.3% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 66.1% | 0.64 |
| FY2024 | 65.4% | 4.52 |
| FY2023 | 60.9% | (3.91) |
| FY2022 | 64.8% | (4.86) |
| FY2021 | 69.7% | 1.68 |
| FY2020 | 68.0% | (1.62) |
| FY2019 | 69.6% | 0.62 |
| FY2018 | 69.0% | 2.66 |
| FY2017 | 66.4% | (3.12) |
| FY2016 | 69.5% | (0.30) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 73.5% | 7.08 |
| Jun 2026 | 66.4% | 0.35 |
| Mar 2026 | 66.1% | 0.60 |
| Dec 2025 | 65.5% | (2.13) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ILMN Illumina, Inc. | 67.9% |
| GH Guardant Health, Inc. compare | 65.2% |
| IDXX IDEXX Laboratories, Inc. compare | 62.7% |
| MTD Mettler-Toledo International, Inc. compare | 60.3% |
| A Agilent Technologies, Inc. compare | 53.8% |
| WAT Waters Corporation compare | 49.5% |
| DGX Quest Diagnostics Incorporated compare | 33.1% |
| IQV IQVIA Holdings Inc. compare | 33.1% |
| LH Labcorp Holdings Inc. compare | 29.0% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement